Agios plunged 48% after its Phase III Pyrukynd trial delivered mixed results, missing key pain-crisis and fatigue endpoints. Despite strong...
Read moreDetailsUS stocks rose on Wednesday, setting up a fourth day win as investors welcomed rising odds of a December rate...
Read moreDetailsPriority Tech faces turmoil as major holder Steamboat blasts the CEO’s go-private bid as too low. With improving results and...
Read moreDetailsSprout Social drew attention after takeover rumors linked Adobe to a possible bid. Strong 13% revenue growth, record margins, and...
Read moreDetailsVoyager’s acquisition of Estes Energetics boosts vertical integration in missile tech, aligning with DoD priorities and strengthening supply-chain control, but...
Read moreDetailsUS stocks were mixed on Tuesday as Wall Street digested fresh retail and inflation data ahead of next month’s highly...
Read moreDetailsKaltura is making waves after agreeing to buy eSelf.ai for $27M, a move that accelerates its shift from video SaaS...
Read moreDetailsAlphabet is approaching a $4 trillion market value after a recent surge that reshaped investor expectations for the future of...
Read moreDetailsPacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist...
Read moreDetailsNasdaq, S&P 500 Rally as Nvidia, Tesla, and Google Power Big Tech Comeback
Read moreDetailsThese Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.
CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE
To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.
If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.